It's long been unclear whether is best to provide chemotherapy before an esophageal cancer surgery only, or whether another dose after surgery might be advisable New research now shows better results when folks got chemo before and after surgery Clarity on this issue is much needed, experts said TUESDAY, June 4, 2024 (Healthday News) -- People battling advanced esophageal cancers should get doses of chemotherapy both before and after tumor-removing surgeries, a new study suggests. “There is considerable disagreement as to whether giving all adjuvant [chemo] therapy upfront versus ‘sandwich’ adjuvant therapy before and after surgery is the better standard of care" for people whose tumors can be removed with surgery, explained researcher Dr Jennifer Tseng , of Boston Medical Center. She wasn't involved in the new trial, but said that "this randomized clinical trial from Europe answers that question for patients similar to those in enrolled in the trial: preoperative plus postoperative chemotherapy provides better outcomes.
” The findings were presented Sunday at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. According to the American Cancer Society , more than 22,000 Americans will be diagnosed with esophageal cancer this year and over 16,000 will die of the illness. Esophageal cancer is much more common among men than women.
The question of when to administer chemotherapy for esophageal cancer has been a matter of debate. The new tri.
